A 6-year, 27,000 patient study published in The Journal Anesthesiology showed that AlertWatch:OR reduced length of stay and hospital charges. Learn more
AlertWatch & Qualcomm
AlertWatch & Qualcomm are proud to announce a strategic partnership. Read more here.
Learn More About AlertWatch
Copyright 2019 AlertWatch. All rights reserved.
AlertWatch:OR and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, and are intended for use by clinicians for secondary monitoring of patients . AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.
AlertWatch:ICU, AlertWatch:AC, and AlertWatch:PACU are pending FDA clearance and are currently only available for IRB-sponsored research. Some images and interfaces are enhanced for clarity.